WallStreetZenWallStreetZen

NASDAQ: TPST
Tempest Therapeutics Inc Stock Ownership - Who owns Tempest Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tempest Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew AngelCEO and President2026-03-24231,482$2.16
$500.00kBuy

1 of 1

TPST insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TPST insiders and whales buy or sell their stock.

TPST Shareholders

What type of owners hold Tempest Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matthew Angel90.07%13,337,047$24.41MInsider
Michelle Dipp53.75%7,959,182$14.57MInsider
Richard Aldrich35.22%5,214,762$9.54MInsider
Christoph H. Westphal30.58%4,527,348$8.29MInsider
Versant Venture Capital VI LP23.69%3,507,056$6.42MInsider
Bessemer Venture Partners VII LP16.15%2,392,034$4.38MInsider
Thomas Woiwode14.75%2,183,788$4.00MInsider
Versant Vantage II LP14.31%2,118,644$3.88MInsider
Longwood Fund LP12.42%1,839,689$3.37MInsider
New Enterprise Associates 15 LP11.93%1,766,407$3.23MInsider

1 of 3

TPST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TPST1.22%98.78%Net BuyingNet Buying
PTN3.98%96.02%Net Buying
SNSE15.96%84.04%Net SellingNet Buying
TRAW11.41%88.59%Net BuyingNet Buying
SKYE2.23%97.77%Net Selling
View Top Biotech Stocks

Tempest Therapeutics Stock Ownership FAQ

Who owns Tempest Therapeutics?

Tempest Therapeutics (NASDAQ: TPST) is owned by 5.31% institutional shareholders, 430.90% Tempest Therapeutics insiders, and 0.00% retail investors. Matthew Angel is the largest individual Tempest Therapeutics shareholder, owning 13.34M shares representing 90.07% of the company. Matthew Angel's Tempest Therapeutics shares are currently valued at $24.27M.

If you're new to stock investing, here's how to buy Tempest Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.